Evaluation of Autologous Engineered Skin Substitute (ESS-W) Compared to Meshed, Split-Thickness Autograft (AG) for Treatment of Deep Partial- and Full-Thickness Thermal Burn Wounds in Adult Patients

Trial Profile

Evaluation of Autologous Engineered Skin Substitute (ESS-W) Compared to Meshed, Split-Thickness Autograft (AG) for Treatment of Deep Partial- and Full-Thickness Thermal Burn Wounds in Adult Patients

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2016

At a glance

  • Drugs Human skin replacement Amarantus Bioscience (Primary)
  • Indications Burns
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Amarantus Bioscience Holdings
  • Most Recent Events

    • 29 Aug 2016 Planned initiation date changed from 1 Apr 2016 to 1 Sep 2016.
    • 23 Feb 2016 Planned initiation date changed from 1 Dec 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov.
    • 19 Oct 2015 Planned End Date changed from 1 Dec 2019 to 1 Jul 2020 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top